{"id":202052,"name":"DEXCOM, INC.","slug":"dexcom-inc","state":"CA","country":"United States of America","description":"","totalSpending":3316705,"filings":37,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":166199},{"year":2020,"income":230756},{"year":2021,"income":229600},{"year":2022,"income":232500},{"year":2023,"income":304400},{"year":2024,"income":833250},{"year":2025,"income":1320000}],"issues":["HCR","MMM","ECN","TRD"],"firms":["DEXCOM, INC."],"lobbyists":["BRUCE TAYLOR","TIM TRYSLA","GREG CRIST","BILLY RAINES","ASHLEY MENZLER"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Office of Management & Budget (OMB)","Commerce, Dept of (DOC)","Executive Office of the President (EOP)","Food & Drug Administration (FDA)"],"sampleDescriptions":["Coverage policy for therapeutic continuous glucose monitoring","Coverage policy for therapeutic continuous glucose monitoring","Medicare Coverage Policy Language for Continuous Glucose Monitoring","Coverage Policy of therapeutic continuous glucose monitoring","CMS Coverage Policy Issues for patient access"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}